1. AHRO : Austin Health Research Online

Alysson Wann

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Alysson Wann
Full Name
Wann, Alysson
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 1-5 of 5 (Search time: 0.008 seconds).

Publication YearTitleAuthor(s)
115-Apr-2021Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study.Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy J; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C 
229-Jan-2021Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study.Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C 
327-Jan-2020Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre.Nguyen, Mike ; Ng Ying Kin, Sean; Shum, Evonne; Wann, Alysson ; Tamjid, Babak ; Sahu, Arvind; Torres, Javier
4Apr-2018Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.Wann, Alysson ; Tully, Patrick A; Barnes, Elizabeth H; Lwin, Zarnie; Jeffree, Rosalind; Drummond, Katharine J; Gan, Hui K ; Khasraw, Mustafa
518-Feb-2016Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian centreWann, Alysson ; Ashley, David M; Khasraw, Mustafa